US Patent Issued to Temple University-Of The Commonwealth System of Higher Education, Praeventix on June 24 for "Modulators of the 5-hydroxytryptamine receptor 7 and their method of use" (Pennsylvania Inventors)

ALEXANDRIA, Va., June 25 -- United States Patent no. 12,338,247, issued on June 24, was assigned to Temple University-Of The Commonwealth System of Higher Education (Philadelphia) and Praeventix LLC (Exton, Pa.).

"Modulators of the 5-hydroxytryptamine receptor 7 and their method of use" was invented by Daniel J. Canney (Ambler, Pa.), Benjamin E. Blass (Eagleville, Pa.), Kevin M. Blattner (Folsom, Pa.) and Douglas A. Pippin (Chester Springs, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activ...